Our Experts

Name: Li Jian
Title: Chief Physician
Email:
Phone:

share
Profile
Jian Li, Ph.D., Master's supervisor, and Chief Physician, currently serves as an Executive Committee Member of the Tumor Interventional Branch of the Society of Organ Medicine and Technology. His primary research focuses on the diagnosis and interventional treatment of tumors using ultrasound, with a particular emphasis on the clinical application of contrast-enhanced ultrasound (CEUS) and elastography in precision oncology. In recent years, he has led key projects, including the National Natural Science Foundation of China General Program (Grant No. 82172019, 2022-2025) and the Clinical Research 308 Project (2019-2024). His research findings have been published in esteemed international journals such as Computerized Medical Imaging and Graphics, BMC Medical Imaging, and Cancer Medicine, and have been presented at prestigious conferences, including EUROSON. As the first or corresponding author, his studies encompass AI-assisted diagnosis of axillary lymph node metastasis in early breast cancer, optimization strategies for ultrasound-guided biopsy, and precision biopsy techniques for anterior mediastinal masses. Notably, his research on CEUS-guided biopsy of anterior mediastinal masses has been incorporated into the Mediastinal Imaging Appropriateness Criteria by the American College of Radiology (ACR), contributing to the standardization and advancement of ultrasound applications in tumor diagnosis and treatment.
Interests
Education
Charite University, Berlin, Germany, Surgical Oncology, Dr.med (2004-2006) ;
Sun Yat-sen University, China, Surgery, Ph.D. (2002-2006) ;
Sun Yat-sen University of Medical Science, China, Clinical Medicine, Master Degree (1998-2000);
Sun Yat-sen University of Medical Science, China, Clinical Medicine, Bachelor Degree (1993-1998).
Publications


1. Gong C, Wu Y, Zhang G, et al. Computer-assisted diagnosis for axillary lymph node metastasis of early breast cancer based on transformer with dual-modal adaptive mid-term fusion using ultrasound elastography. Comput Med Imaging Graph. Published online November 26, 2024.

2. Liu X, Huang YN, Wu YL, Zhu XY, Xie ZM, Li J. The value of quantitative shear wave elastography combined with conventional ultrasound in evaluating and guiding fine needle aspiration biopsy of axillary lymph node for early breast cancer: implication for axillary surgical stage. BMC Med Imaging. 2024;24(1):229. Published 2024 Aug 30.

3. Chen R, Cai N, Luo Z, Wang H, Liu X, Li J. Multi-task banded regression model: A novel individual survival analysis model for breast cancer. Comput Biol Med. 2023 Aug;162:107080. doi: 10.1016/j.compbiomed.2023.107080. Epub 2023 May 29.

4. Fang, H., Cai, N., Zhou, J. Li J et al. Automatic detection of ultrasound breast lesions: a novel saliency detection model based on multiple priors. 2022. SIViP 16, 723–734.

5. Chi PD, Liu YJ, Huang YH, Mao MJ, Wang Y, Li ZM, Li J. Rinsing sampling of core needle biopsy for flow cytometric analysis: A favorable method for lymphoma diagnosis. Cancer Med. 2020 Oct 17.

6. Li J, Han J, Wang Y, Mo Y, Li J, Xiang J, Li Z, Zhou J, Wang S. Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma. Front Oncol. 2020 Oct 7.

7. Zhao HW, Li J, Cao JZ, Lin J, Wang Z, Lv JY, et al. Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer.BMC Urology.2020;20:100.

8. Chen BB, Li J, Guan Y, Xiao WW, Zhao C, Lu TX, et al. The value of shear wave elastography in predicting for undiagnosed small cervical lymph node metastasis in nasopharyngeal carcinoma: A preliminary study. European journal of radiology. 2018;103:19-24.

9. Zhou JH, Shan HB, Ou W, Mo YX, Xiang J, Wang Y, et al. Contrast-Enhanced Ultrasound Improves the Pathological Outcomes of US-Guided Core Needle Biopsy That Targets the Viable Area of Anterior Mediastinal Masses. BioMed research international. 2018;2018:9825709. 



Updated by International Office, Sun Yat-sen University Cancer Center

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.